University of Wisconsin
Pathology residency · Madison, WI · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of Wisconsin–Madison's research in pathology, which the program shares with other departments and affiliated hospitals.
About University of Wisconsin–Madisoninstitution-wide pathology research
Pathology publications from University of Wisconsin–Madison and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
66
works per year
22nd of 65 pathology residency programs
-3.7%
2-year growth
43rd of 65 pathology residency programs
26.0%
in top 10% of field (works before 2025)
4th of 56 pathology residency programs
50.5%
cited above world average
5th of 56 pathology residency programs
Works per year · * 2026 so far
Pathology and Forensic Medicine · 333
Pathology research topics at University of Wisconsin–Madison
Papers in the window; each links to the list on OpenAlex.
Most cited at University of Wisconsin–Madison since 2024
All pathology papers there on OpenAlex
- Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and HowsAndrea Giustina et al. · Endocrine Reviews · 2024 · PubMed · cited 392
- Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric, Version 3.2024, NCCN Clinical Practice Guidelines In OncologyRachel Hodan et al. · Journal of the National Comprehensive Cancer Network · 2024 · PubMed · cited 126
- Designing clinical trials to address alcohol use and alcohol-associated liver disease: an expert panel Consensus StatementBrian P. Lee et al. · Nature Reviews Gastroenterology & Hepatology · 2024 · PubMed · cited 64
- The histological and molecular characteristics of early-onset colorectal cancer: a systematic review and meta-analysisThomas Lawler et al. · Frontiers in Oncology · 2024 · PubMed · cited 59
- Advances and Challenges of Endoscopic Spine SurgeryDaniel J. Burkett et al. · Journal of Clinical Medicine · 2024 · PubMed · cited 53
- Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamabTaylor Brooks et al. · Blood · 2025 · PubMed · cited 45
- NCCN Guidelines® Insights: B-Cell Lymphomas 3.2025Andrew David Zelenetz et al. · Journal of the National Comprehensive Cancer Network · 2025 · PubMed · cited 28
- The sodium-glutamate antagonist riluzole improves outcome after acute spinal cord injury: results from the RISCIS randomised controlled trial analysed using a global statistical analytic techniqueMichael George Fehlings et al. · EBioMedicine · 2025 · PubMed · cited 22
- Is there a safe limit for consumption of alcohol?Jessica Musto et al. · Journal of Hepatology · 2024 · PubMed · cited 18
- Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphomaNguyet-Minh Hoang et al. · Cell Reports Medicine · 2024 · PubMed · cited 18